Adaptive Biotechnologies Corp
ADPT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001478320
In the last 90 days, Adaptive Biotechnologies Corp insiders filed 0 open-market purchases and 13 sales; 301 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; superinvestors Viking Global Investors and ARK Invest hold it.
Q4 2024 vs. Q3 2024
How the institutions holding Adaptive Biotechnologies Corp changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 187 | 3 | 207 | +23 |
| Shares | 143.1M | 330.5K | 143.3M | +508.3K (+0.4%) |
| Value | $732.5M | $1.69M | $858.6M | +$127.8M (+17.5%) |
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held Adaptive Biotechnologies Corp at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (23)
Institutions that held Adaptive Biotechnologies Corp at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Matrix Capital Management Company, LP | 650,000 | $3.33M |
| Jump Financial, LLC | 120,020 | $614.5K |
| Primecap Management Co | 76,030 | $389.3K |
| American Century Companies Inc | 71,165 | $364.4K |
| Engineers Gate Manager LP | 56,413 | $288.8K |
| Gsa Capital Partners LLP | 48,165 | $247.0K |
| EntryPoint Capital, LLC | 47,520 | $243.3K |
| National Asset Management, Inc. | 20,000 | $102.4K |
| Point72 (DIFC) Ltd | 19,637 | $100.5K |
| Centiva Capital, LP | 15,635 | $80.1K |
| Veriti Management LLC | 14,815 | $75.9K |
| Personal Cfo Solutions, LLC | 11,250 | $57.6K |
| DLK Investment Management, LLC | 10,100 | $51.7K |
| Ashton Thomas Securities, LLC | 6,685 | $34.2K |
| Catalyst Funds Management Pty Ltd | 2,000 | $10.2K |
| Group One Trading, L.P. | 1,619 | $8.29K |
| Capital Performance Advisors LLP | 764 | $3.91K |
| Bokf, NA | 116 | $587 |
| SRS Capital Advisors, Inc. | 97 | $497 |
| Ronald Blue Trust, Inc. | 91 | $329 |
| Northwestern Mutual Wealth Management Co | 24 | $123 |
| Avion Wealth | 140 | $0 |
| Hemington Wealth Management | 200 | $0 |
Not filed for Q4 2024 yet (3)
Institutions that held Adaptive Biotechnologies Corp at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Millrace Asset Group, Inc. | 272,681 | $1.40M |
| AJOVista, LLC | 56,270 | $288.1K |
| Abich Financial Wealth Management LLC | 1,524 | $7.80K |